Abstract
The hepatitis C virus (HCV)-specific CD4+ T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4+ T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by > or = 40% of patients, and specific CD4+ T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class II molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4+ T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4+ T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.
MeSH Terms
Adolescent
Adult
Alleles
Amino Acid Sequence
Antigen Presentation
CD4-Positive T-Lymphocytes/immunology
Female
HLA Antigens/genetics,physiology
Hepacivirus/immunology
Hepatitis C/immunology
Humans
Immunodominant Epitopes
Leukocytes, Mononuclear/immunology
Lymphocyte Activation
Male
Middle Aged
Molecular Sequence Data
Viral Nonstructural Proteins/immunology
Chemicals
HLA Antigens
Immunodominant Epitopes
NS3 protein, hepatitis C virus
NS4 protein, hepatitis C virus
Viral Nonstructural Proteins
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Gerlach J T
Department of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland. Tilman.Gerlach@usz.ch
Ulsenheimer A
Grüner N H
Jung M-C
Schraut W
Schirren C-A
Heeg M
Scholz S
Witter K
Zahn R
Vogler A
Zachoval R
Pape G R
Diepolder H M
References (19)
19 references, click to expand
-
Hepatitis C virus infection in the United States.
J Hepatol. 1999;31 Suppl 1:88-91
PMID: 10622567
-
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.
Gastroenterology. 1999 Oct;117(4):933-41
PMID: 10500077
-
Clinical significance of hepatitis C virus genotypes and quasispecies.
Semin Liver Dis. 2000;20(1):103-26
PMID: 10895435
-
Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
Eur J Immunol. 2001 May;31(5):1438-46
PMID: 11465100
-
Determinants of viral clearance and persistence during acute hepatitis C virus infection.
J Exp Med. 2001 Nov 19;194(10):1395-406
PMID: 11714747
-
Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
Hepatology. 2002 May;35(5):1225-36
PMID: 11981773
-
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.
J Virol. 2002 Dec;76(24):12584-95
PMID: 12438584
-
Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
Hepatology. 2003 Mar;37(3):577-89
PMID: 12601356
-
Definition of supertypes for HLA molecules using clustering of specificity matrices.
Immunogenetics. 2004 Mar;55(12):797-810
PMID: 14963618
-
Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
J Viral Hepat. 2004 Jul;11(4):324-31
PMID: 15230855
-
Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
Hepatology. 2004 Jul;40(1):87-97
PMID: 15239090
-
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
Hepatology. 1995 Mar;21(3):632-8
PMID: 7875660
-
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.
Lancet. 1995 Oct 14;346(8981):1006-7
PMID: 7475549
-
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
J Clin Invest. 1996 Aug 1;98(3):706-14
PMID: 8698862
-
Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity.
Hepatology. 1997 Feb;25(2):449-58
PMID: 9021963
-
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
J Virol. 1997 Aug;71(8):6011-9
PMID: 9223492
-
Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus.
Int Immunol. 1999 Apr;11(4):577-83
PMID: 10323211
-
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
Hepatology. 1999 Oct;30(4):1088-98
PMID: 10498664
-
Analysis of successful immune responses in persons infected with hepatitis C virus.
J Exp Med. 2000 May 1;191(9):1499-512
PMID: 10790425